The current review summarizes and discusses current research on differences elicited between sugars and nonnutritive sweeteners via sugar-sensing pathways.
INTRODUCTION
The use of sweeteners and sweetness enhancers is increasing, partly in response to WHO and governmental initiatives set out to reduce sugar consumption. Sweeteners are primarily described by whether they are broken down to provide energy or not. The term nutritive sweeteners encompass all sweetening agents that provide energy (as kcal/g), whereas nonnutritive sweeteners (NNS) are undigested and, therefore, provide negligible energy content. The nutritive sweeteners category can be further broken down into sugars (glucose, fructose, sucrose, dextrose) including honey and maple syrup, or polyols -sugar alcohols such as sorbitol, mannitol, and xylitol -also known as bulk sweeteners. All nutritive sweeteners are metabolized by the body, however, polyols provide lower energy compared to sugars (1-2 and 4 kcal/g, respectively) [1] . The majority of NNS are artificially synthesized (hence, artificial sweetener), however, some are derived from natural sources; steviol glycosides is a natural extract from Stevia rebaudiana [2] . All of these compounds stimulate oral sweet taste perception through activation of the sweet taste receptor; a heterodimer of type 1 taste receptor 2 (T1R2)/type 1 taste receptor 3 (T1R3) [3] . The T1R2/T1R3 sweet taste receptor is expressed not only in the oral cavity but also in several gut cells, indicating a role in gut nutrient sensing [3] . In this review, recent investigations into the physiological response to activation of the T1R2/T1R3 receptor in the oral cavity and gut in response to both sugars and sweeteners are summarized and discussed.
The evolved importance of sugar and sweetness
Human metabolism uses glucose as the primary energy currency; glucose is derived from dietary intake upon the digestion and subsequent absorption of complex and simple carbohydrates. Plantderived foods are the richest source of mono and disaccharides, and progressive hydrolysis of complex carbohydrates such as starch, ultimately provides large amounts of glucose. Fruits, nuts, and berries contain high amounts of simple mono and disaccharides such as glucose, fructose, maltose, and sucrose. Digestion of starchy roots and tubers, that is, potatoes, yams, cassava, along with cereals and grains such as wheat, barley, rice, and millet yield large quantities of glucose. Natural sugars and sweeteners exist in the form of honey, maple syrup, carob, and sucrose (table sugar) has been extracted from sugar cane (Saccharum officinarum) and sugar beets (Beta vulgaris) since the 18th Century [2] . These nutritive sweeteners have been used in food preparation for many years, however, more recently, the use of polyols and NNS has increased [1] .
Humans have consumed sugars throughout evolution, and it is believed that carbohydrates were an increasingly important component of hominin diets, since the advent of cooking [4] . It has been suggested that cooked carbohydrates and sugars were integral to our evolution and survival to support increased energy demands of human's relatively increased cranial capacity [4, 5] . Given the high energy demands of the human brain (20% of total energy intake), a mechanism to quickly identify sweet and nutrient-dense foods would have provided a survival advantage. This has led to the evolution of complex and discreet nutrient-sensing pathways both in the oral cavity and the gut.
Despite the necessity for sugar and carbohydrate intake during evolution, evidence suggests chronic high sugar consumption in the modern dietary and lifestyle landscape, may contribute toward detrimental energy homeostasis [6, 7] . Over the past 20 years the United Kingdom has experienced a dramatic rise in the incidence of type-2 diabetes mellitus (T2DM) and a near parallel increase in obesity rates -itself a principal risk factor for T2DM development. Despite the multifactorial risk factors for both T2DM and obesity including hereditary genetic and lifestyle components, diet and lifestyle management is pivotal to reducing the incidence of T2DM [8] .
Changes in sugar intake guidelines
The Scientific Advisory Committee on Nutrition's review on the role of dietary carbohydrates in health [7] , and the 2015 changes to the WHO dietary guidelines [9] , both proposed a reduction in sugar consumption. There has been increased focus of healthcare professionals and organizations to encourage the public to reduce sugar consumption. Current recommendations are that sugar should contribute up to 10% of daily caloric intake; 30 g adults, and 19 g children [9] . Potential health benefits of a reduction in sugar intake, include the correlated reduction in total energy intake, which may help prevent obesity, and reduce risk of dental caries [7, 10] . This has led to increased use of NNS, which provide sweetness in the absence of calories, such as polyols, aspartame, sucralose, and acesulfame-k (Ace-K) in the food and beverage industry, largely because of their associated health benefits.
Oral sweet taste perception and sugar sensing
Humans perceive a diverse range of chemical compounds as sweet tasting, including sugars (glucose, fructose, sucrose, maltose), polyols (sorbitol, erythritol), artificial sweeteners (saccharin, aspartame, cyclamate), sweet amino acids (d-tryptophan, d-phenylalanine, d-serine), and sweet proteins (monellin, brazzein, thaumatin). NNS approved for use in the Europe include aspartame, sucralose, saccharin, Ace-K, cyclamate, neohesperidin, and steviol glycosides [2] . All of these ligands stimulate oral sweet taste perception through activation of the sweet taste receptor.
The human sweet taste receptor is a transmembrane heterodimer of T1R2 and T1R3, respectively. Expression of TAS1R2 and TAS1R3 genes encoding T1R2 and T1R3 respectively, have been reported in the circumvallate papillae and foliate papillae taste receptor cells in the mouth [11] . Both T1R2 and T1R3 belong to Class C of G protein-coupled receptors and feature the distinct N-terminal Venus flytrap domain (VFT), connected by a short cysteinerich linker region to the seven transmembrane domain, typical of Class C G protein-coupled receptors s [12] .
The T1R2 and T1R3 VFT domains carry different binding sites, with different affinities for sugars and sweeteners. Glucose, sucrose, and sucralose can bind to the VFT domain of both T1R2 and T1R3. T1R2 shows broader specificity for natural sugars and NNS, including aspartame, whereas cyclamate can activate T13R through binding to the seven transmembrane domain, rather than the VFT domain. Furthermore, sweet tasting proteins (e.g. thaumatin
KEY POINTS
The sweet taste receptor, T1R2/T1R3, is found in the oral cavity and throughout the intestine and binds both nutritive sweeteners (i.e. glucose, fructose, sucrose) and NNS (i.e. aspartame, Ace-k, sucralose).
The evidence on whether NNS have an impact on incretin hormone secretion and glycemia in humans is unclear, with the majority of studies reporting no significant effects.
The negligible caloric content in NNS may be the reason for the lack of physiological effect as the T1R2/ T1R3 receptors may have evolved in humans to distinctly recognize sweet-tasting molecules that provide energy.
and monellin), achieve activation through simultaneous binding of regions on T1R2 and T1R3 [13] .
Ligand-binding of T1R2/T1R3 on the apical surface of taste cells activates the release of G-protein agustducin. However, there is evidence that different pathways can then be triggered by natural sugars versus sweeteners. Stimulation of the GCPRs by natural sugars leads to adenylate cyclase activation that depolarizes the taste cell, leading to increased Cyclic Adenosine Monophosphate concentration, this can then either directly or indirectly close basolateral potassium channels, ultimately resulting in neurotransmitter release [13] .
Alternatively, binding from sweeteners leads to phospholipase C b2 activation -rather than adenylate cyclase -that produces intracellular release of Ca 2þ which in-turn activates the transient receptor potential cation channel M5, resulting in adenosine triphosphate release. Ultimately, binding of sweet taste receptors results in sweet taste perception through neurotransmitter release either from direct changes in depolarization or by second messengermediated changes in intracellular Ca 2þ concentration. Currently, it is believed that both pathways are triggered from the same taste cell [13] . The pathways result in stimulation of sensory neurons that send signals to brain centres involved in taste perception and the reward centres. It has been suggested that there are separate, yet integrated, neuronal circuits involved in taste perception and nutritional value yet it remains largely unknown if oral and gut T1R2/ T1R3 use the same neural circuitries [14] . Currently, the evidence for nutritional evaluation of sweetness appears to be a result of gastric glucose availability [14] .
Oral perception of sweetness is described by the intensity and duration of sweetness experienced; this has been associated to differences in binding patterns to the multiple binding sites of T1R2/T1R3 [15] . Often, polyols and NNS are used in varying combinations to achieve a combined sweetness profile similar to sucrose, whereas providing a healthy, low-energy burden. Many NNS are considered highintensity sweeteners as they are many times sweeter than sucrose, that is, saccharin 200-700x, sucralose is 600x sweeter, and aspartame and Ace-K are both 200x. Therefore, they are often used at much lower concentrations than sucrose to provide equivalent sweetness to food and beverages [1] .
Sugars, nutritive sweeteners, and NNS are all perceived as sweet tasting because of their ability to bind to the T1R family of sweet taste receptors in the oral cavity. This triggers the sweetness transduction cascade, in the case of glucose and other glucose-containing sugars, this elicits a cephalic response, however, evidence suggests this response is absent after NNS consumption [16] . The cephalic response leads to glucagon-like peptide 1 (GLP-1) release which prompts sugar transporters to localize, stimulates release of insulin, thus promoting glucose clearance from the blood.
Gut sugar sensing and signalling
Nearly, a decade has passed since the discovery of TAS1R2 and TAS1R3 expression in intestinal enterocytes and enteroendocrine cells. There is evidence for the colocalization of T1R2/T1R3 and a-gustducin, in human intestinal epithelium, and that T1R2/T1R3 becomes activated in the lumen in the presence of sweet nutrients, much like in the oral cavity [17 && ]. A secondary mechanism of luminal glucose sensing has been proposed in the hormone producing enteroendocrine cells of the intestine. Under conditions of luminal glucose concentrations more than 30 mM, sodium-dependent glucose co-transporter 1 increases cotransportation of glucose and Naþ into the cell, increasing the cells electrogenicity. This generates action potentials and triggers cell membrane depolarization and Ca þ2 entry into the cell [18] . This signalling cascade results in the secretion of numerous gut hormones, including the incretin hormones; GLP-1, and glucose-dependent insulinotropic peptide (GIP) [18] .
These incretin hormones are vital in reducing blood glucose concentration, through their insulinotropic activity. Once secreted they travel and act upon their respective receptors on pancreatic b-cells to stimulate insulin secretion and synthesis [19] . GLP-1 is also involved in appetite regulation by interacting with its receptors located on the brain and stomach, decreasing food intake and increasing satiety, and decreasing gastric emptying, respectively [20] . Evidence supporting T1R2/T1R3 and a-gustducin's direct involvement in GIP secretion, however, is lacking [17
Differences in nonnutritive sweetener sensing
NNS are thought to interact and activate the sweet taste receptors in the gut as they do in the mouth. Sucralose has been shown to be an agonist for T1R2/ T1R3 receptors, resulting in incretin secretion in vitro, with both mouse and human enteroendocrine cell lines [21] . However, the concentration of sucralose used (50 mM) is typically much higher than normal luminal concentrations (0.04-0.1 mM), therefore extrapolation into a relevant physiological response is limited.
Using perfused rat small intestines, Saltiel et al.
[17 && ] demonstrated that intraluminal doses of sucralose, stevioside, and Ace-K did not elicit GIP secretion, and only Ace-k stimulated GLP-1 release. Interestingly, intravascular dosing of sucralose and stevioside induced both GLP-1 and GIP secretion, whereas Ace-K did not stimulate any incretin release. These results suggest gut sweet taste receptors may be basolaterally located, in which case, sucralose and stevioside are unlikely to be capable of eliciting a response in vivo as they do not cross the brush-border membrane. However, Ace-k's ability to induce GLP-1 secretion indicate that there may be some apically located receptors. It is possible that GLP-1 secretion may only be stimulated through some specific ligand-binding to T1R2/T1R3 with certain NNS being able to interact with the sweet taste receptors and other unable to, though further research is needed to test this hypothesis.
The traditional understanding is that NNS can be used to help lower or control blood glucose levels. In vitro and ex vivo rodent studies provided evidence that NNS may increase glucose uptake in intestinal epithelium cells by activating T1R2/T1R3 and a-gustducin which may signal another transporter -the glucose transporter (GLUT)2 transporter -to translocate to the apical membrane and up-regulate glucose transport [22] . Similarly, preincubation of Caco-2 cells with Ace-K was reported to promote glucose uptake only in glucose concentrations more than 25 mM, suggesting saturation of -dependent glucose co-transporter 1 increased glucose uptake in the presence of Ace-K, via GLUT2 translocation [22] . However, in a similar study, Caco-2 cells preincubated with the sweet taste receptor inhibitor lactisole had no effect on glucose uptake at concentrations of glucose ranging from 2.5 to 75 mM, and Ace-K and sucralose produced no significant differences in glucose uptake 
CONCLUSION
The evolved redundancy of the sweet taste receptor to become activated by such a wide variety of chemical ligands, highlights the importance of sweettasting foods. Within an evolutionary context, a mechanism to quickly identify sweet and by association, nutrient-dense foods would have provided a survival advantage. However, in the modern dietary landscape, where not all sweet-tasting molecules provide caloric energy, it appears the brainvia reward centres -and body -via glucose homeostasis -is able to access and respond appropriately to caloric versus noncaloric sweeteners.
Recent research has focused on laying the foundation of understanding nutrient-sensing pathways in the gut via the T1R family of sweet taste receptors. Animal studies, and human in-vitro research suggests NNS can activate the gut sweet taste receptors, and under some conditions elicit incretin hormone release. However, the preponderance of evidence from human studies suggest NNS have no effect on glucose metabolism. This highlights the importance of understanding differences in the physical binding of the T1R2/T1R3 proteins and their subsequent variance in the transduction cascade, and neuronal signalling in understanding the differences in physiological response between sugars, nutritive sweeteners and NNS.
O'Brien P, Corpe CP. Acute effects of sugars and artificial sweeteners on small intestinal sugar transport: a study using CaCo-2 cells as an in vitro model of the human enterocyte. PLoS One 2016; 11:e0167785. Using physiologically relevant doses, this study found no increase in glucose uptake in eneterocyte, when incubated in sucralose and Ace-k; contrary to previous older studies. 24. The double-blind randomized control study is one of few to investigate the effects of sucralose on glucose homeostasis over a long-time period. The results found no significant differences in blood glucose and insulin levels between the control and experimental groups-indicating chronic sucralose consumption may not have any detrimental consequences in a healthy population.
